Through increased insulin secretion and reduced glucagon in post-meal phases, the drug maintains blood glucose stability
In clinical trials, liraglutide 1.8 mg and 3 mg daily led to a mean reduction of 4.7% and 6% of body weight, respectively, after 56 weeks, compared to 2% with the placebo group
By addressing both appetite regulation and glucose control, Ozempic offers a comprehensive approach to weight loss, making it an effective option for individuals looking to manage their weight long-term
Misuse and abuse: Pills may be easier to conceal, share, or overuse than injectables
In relation to metabolic syndrome, which includes risk factors that raise the chances of heart disease, stroke, and type 2 diabetes, GLP-1 and GIP supplements can address multiple issues at once